The bill increases accountability and transparency around alleged state‑sponsored organ harvesting and protects aid and trade continuity, but it risks slowing legitimate research, straining diplomacy, creating economic/legal spillovers for U.S. institutions, and leaving some enforcement tools and definitions constrained or uncertain.
Alleged perpetrators (foreign persons and officials tied to state-sponsored organ harvesting) will be blocked from U.S. property, transactions, and entry, reducing their ability to use U.S. financial systems or travel and increasing accountability for human-rights abuses.
U.S. coordination with allies and multilateral institutions will be leveraged to amplify pressure on actors engaged in organ trafficking and forced organ removal, strengthening international norms and collective action.
Patients and U.S. medical institutions will be less likely to be complicit in unethical transplant practices because the bill discourages cooperation with entities implicated in forced organ removal.
Researchers, patients, and scientific collaborations could be harmed because restricting cooperation with PRC researchers and public disclosure of past collaborations may slow legitimate transplant research and chill scientific partnerships.
U.S. diplomatic relations and cooperation on other global issues could be strained, and the bill risks retaliatory measures from affected countries that could affect trade, consular services, or other collaborations.
Universities, hospitals, nonprofits, and businesses may face economic spillovers—asset blocks, transaction bans, or administrative burdens—disrupting legitimate contracts and partnerships with foreign counterparts.
Based on analysis of 6 sections of legislative text.
Directs targeted sanctions and visa restrictions and requires a government report to pressure China over alleged involuntary organ harvesting and to limit transplant cooperation.
Official title: Falun Gong Protection Act
Introduced February 24, 2025 by Scott Perry · Last progress May 6, 2025
Directs the U.S. to condemn and act against alleged state-sponsored involuntary organ harvesting in the People’s Republic of China by requiring targeted sanctions, visa restrictions, and public reporting. It directs the President to identify and sanction foreign persons involved in involuntary organ harvesting, requires a State Dept. report (with HHS/NIH input) on PRC transplant practices, and limits certain types of cooperation while preserving narrow humanitarian and intelligence exceptions. The law sets deadlines for lists and reports (initial sanctions list within 180 days, an in-depth organ-transplant report within one year), includes waiver and exception authorities, and sunsets the sanctions-authority after five years.